Serial Number:
77281154
Mark:
DEFEND +
Status:
Abandoned-No Statement of Use filed
Status Date:
04-16-2012
Filing Date:
Registration Number:
N/A
Registration Date:
N/A
Billing services and referral services in the field of treatment for cancer, chemotherapy and pharmaceutical products; referral services in the field of pharmaceutical products offered in conjunction with educational support programs; Administration of patient reimbursement programs Educational services, namely, development and dissemination of educational materials of others in the field of pharmaceutical products and treatment of medical disorders; conducting seminars regarding the use of prescription pharmaceutical products for medical disorders; providing a motivational and educational speaker featuring information regarding medical disorders Medical research, namely, clinical trial services; pharmaceutical research and development services Patient support services relating to treatment of medical disorders, namely, pharmaceutical advice and consultation in the nature of providing online information regarding pharmaceutical preparations for treatment of various diseases; providing health and medical information about medical disorders; information services, namely, providing medical information to cancer patients; information services relating to medical services via a global computer network, namely, providing medical consultancy and advisory services via a global computer network
Mark Description:
The mark consists of the word "DEFEND" below a plus symbol. The portion of the mark comprised of a cross design is not displayed in the color red or a colorable imitation thereof. Applicant does not use and will not use the cross design that appears in its mark in the color red or a colorable imitation thereof.
Class:
Medical services
Type of Mark:
Servicemark
Published for Opposition Date:
06-10-2008
Owner:
Mark Drawing Status:
Words, Letters, and/or Numbers in Stylized From
Abandon Date:
04-16-2012
Business Name:
DLA PIPER LLP (US)
Correspondent Name:
